secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dogwood Therapeutics, Inc. (DWTX)
CIK:        0001818844
Form:       8-K
Filed at:   2024-02-27T23:59:59+00:00
Accession:  0001558370-24-001840
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Virios Therapeutics cuts cash compensation 10%; grants stock options to officers and directors
--------------------------------------------------------------------------------

- Board approved 10% salary reduction for all employees including executive officers, effective March 1, 2024.
- Non-employee director cash compensation also reduced by 10%.
- Stock options granted to executive officers and directors: CEO Greg Duncan receives 138,835 options; total 410,570 options across 10 recipients.
- Options have exercise price of $0.357/share and vest on February 26, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818844/000155837024001840/0001558370-24-001840-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818844/000155837024001840/tmb-20240226x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-001840

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer